The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism and atherosclerosis.
Abstract
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It also influences the expression of hyperlipidemia and appears to modulate the susceptibility to atherosclerosis in a complex multifactorial interaction. There is evidence that the presence of apo E2 is protective, whereas that of apo E4 predisposes to coronary artery disease. The burden of proof, however, lies on future, well-designed clinical trials and prospective studies. The study of the biological significance of the apo E polymorphism in humans has emphasized the importance of gene-gene and gene-environment interactions in the pathogenesis of hyperlipidemia and atherosclerosis. The apo E polymorphism involves the coding region of the apo E gene and results in alterations of the gene product which, in turn, either directly or secondarily affect the metabolic fate of the lipoprotein particles. Rapid advances in knowledge over the last decade have provided a metabolic explanation for the observation of the opposite effects of the epsilon 4 and the epsilon 2 alleles on lipoprotein levels. Apo E2 has lower receptor binding affinity which results in delayed clearance of apo E2-bearing lipoprotein particles from plasma. Apo E4 is distributed differently from apo E3 between VLDL and HDL, is degraded more rapidly than apo E3, and may enhance the catabolism of E4-bearing particles, leading to other alterations in lipoprotein metabolism which result in elevated levels of LDL. In view of the significant opposite impacts of the epsilon 4 and the epsilon 2 alleles on plasma LDL cholesterol concentrations, it is evident that determination of the apo E phenotype will become a useful adjunct to the assessment of the cardiovascular risk profile of an individual. In addition, the relationship between the epsilon 2 allele and type III hyperlipoproteinemia provides a valuable model for the study of complex genetic interactions in the pathogenesis of hyperlipidemia. The further study of apo E and its interactions shows great promise for a deeper comprehension of the pathogenesis of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical role of APOE in lipid metabolism is underscored by evidence showing that APOE2 homozygosity can lead to Hyperlipoproteinemia type III (HLP), characterized by mixed hypercholesterolemia and hypertriglyceridemia [35–39].”
In the citing paper
“This observation, coupled with evident mixed hypercholesterolemia and hypertriglyceridemia, supports the characterization of APOE2hAβ rats as a model for type III HLP”
In the citing paper
“Both the ε2 and the ε4 alleles are associated with unfavorable lipid profiles [8][9][10][11][12][13].”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [13]
In the citing paper
“It is estimated that less than one in 20 individuals with the ε22 genotype will have overt type III hyperlipoproteinemia [24].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“At the level of an individual the effect of the APOE polymorphism on plasma lipid levels is moderate, however since the APOE polymorphism is common, it contributes substantially to the total phenotypic variability in plasma lipid levels in the general population [21,24,58].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“The pattern of associations between the six common APOE genotypes and plasma lipid levels is similar across populations, although the magnitude of the associations differs between populations and subgroups within populations; thus both context-dependent and invariant associations could be suggested [9,24,30].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“Both ɛ2 and ɛ4 alleles are associated with unfavourable lipid profiles,12–19”
From Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) · cites this paper as [18]
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [42]
Citations
Cites
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Apolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Cited by
Sorted by citations
Items 501–600 of 1,005
Srinivasan, S. R., Ehnholm, C., Elkasabany, A., & Berenson, G. S. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00304-9 · Cited by 61
Apolipoprotein E ε2 Allele and Risk of Stroke in the Older Population
Ferrucci, L., Guralnik, J. M., Pahor, M., Harris, T. B., Corti, M.-C., Hyman, B. T., Wallace, R. B., & Havlik, R. J. (1997) · Stroke · doi:10.1161/01.str.28.12.2410 · Cited by 61
Abnormal Lipoprotein and Apolipoprotein Pattern in Lipoprotein Glomerulopathy
Oikawa, S., Suzuki, N., Sakuma, E., Saito, T., Namai, K., Kotake, H., Fujii, Y., & Toyota, T. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80649-4 · Cited by 60
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
Shajith Anoop, S., Misra, A., Meena, K., & Luthra, K. (2010) · PubMed · Cited by 60
Donnelly, L. A., Palmer, C. N. A., Whitley, A. L., Lang, C. C., Doney, A. S. F., Morris, A. D., & Donnan, P. T. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f60aad · Cited by 60
Kypreos, K. E., Karagiannides, I., Fotiadou, E. H., Karavia, E. A., Brinkmeier, M. S., Giakoumi, S. M., & Tsompanidi, E. M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07301.x · Cited by 61
Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population
MacLeod, M. J., de Lange, R. P. J., Breen, G. D., Meiklejohn, D. J., Lemmon, H. A., & Clair, D. S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00851.x · Cited by 60
Apolipoprotein E in the brain and its role in Alzheimer's disease.
Poirier, J. (1996) · PubMed Central · Cited by 60
Are cerebrovascular factors involved in Alzheimer’s disease?
Kudo, T., Imaizumi, K., Tanimukai, H., Katayama, T., Sato, N., Nakamura, Y., Tanaka, T., Kashiwagi, Y., Jinno, Y., Tohyama, M., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00129-9 · Cited by 66
The association between APOE and dementia does not seem to be mediated by vascular factors
Prince, M. J., Lovestone, S., Cervilla, J. A., Joels, S., Powell, J. F., Russ, C., & MANN, A. H. (2000) · Neurology · doi:10.1212/wnl.54.2.397 · Cited by 60
Klos, K. L. E., Kardia, S. L. R., Ferrell, R. E., Turner, S. T., Boerwinkle, E., & Sing, C. F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.971 · Cited by 60
Self-citationLohse, P., Brewer, H., Meng, M., Skarlatos, S., LaRosa, J., & Brewer, H. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41380-x · Cited by 59
Fukumoto, H., Ingelsson, M., Gårevik, N., Wahlund, L.-O., Nukina, N., Yaguchi, Y., Shibata, M., Hyman, B. T., Rebeck, G. W., & Irizarry, M. C. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00088-8 · Cited by 63
The Apolipoprotein E E4 Allele and Sex-Specific Risk of Alzheimer's Disease
Corder, E. H. (1995) · JAMA · doi:10.1001/jama.1995.03520290025013 · Cited by 59
Gene–environment interaction and oxidative stress in cardiovascular disease
Stephens, J. W., Bain, S. C., & Humphries, S. E. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.003 · Cited by 59
Specificity of the fivefold increase in AD in mothers of adults with Down syndrome
Schupf, N., Kapell, D., Nightingale, B., Lee, J. H., Mohlenhoff, J., Bewley, S., Ottman, R., & Mayeux, R. P. (2001) · Neurology · doi:10.1212/wnl.57.6.979 · Cited by 59
Vascular risk and genetics of sporadic late-onset Alzheimer’s disease
Panza, F., D’Introno, A., Colacicco, A. M., Basile, A. M., Capurso, C. A., Kehoe, P. G., Capurso, C. A., & Solfrizzi, V. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0071-1 · Cited by 60
Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study
Slooter, A. J. C., van Duijn, C. M., Bots, M. L., Ott, A., Breteler, M. M. B., Voecht, J. D., Wehnert, A., de Knijff, P., Havekes, L. M., Grobbee, D. E., et al. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_3 · Cited by 59
Evans, A. E., Zhang, W., Moreel, J. F. R., Bard, J., Ricard, S., Poirier, O., Tiret, L., Fruchart, J., & Cambien, F. (1993) · Human Genetics · doi:10.1007/bf00219691 · Cited by 59
Loktionov, A., Bingham, S. A., Vorster, H. H., Jerling, J. C., Runswick, S. A., & Cummings, J. H. (1998) · British Journal Of Nutrition · doi:10.1079/bjn19980024 · Cited by 59
Women have a larger and less atherogenic low density lipoprotein particle size than men
Nikkilä, M. T., Pitkäjärvi, T., Koivula, T. A., Solakivi, T., Lehtimäki, T. J., Laippala, P. J., Jokela, H., Lehtom̈aki, E., Seppä, K., & Sillanaukee, P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05645-9 · Cited by 59
Predictive Value of APOE Genotyping in Incipient Alzheimer's Diseasesa
Petersen, R. C., Waring, S. C., Smith, G. E., Tangalos, E. G., & Thibodeau, S. N. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32599.x · Cited by 58
Physiological Factors Influencing Vitamin E Biokinetics
Lodge, J. K., Hall, W. L., Jeanes, Y., & Proteggente, A. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.006 · Cited by 58
Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
Weisgraber, K. H., Pitas, R. E., & Mahley, R. W. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90212-7 · Cited by 58
Watts, G. F., Naoumova, R. P., Cummings, M. H., Umpleby, A. M., Slavin, B. M., Sönksen, P. H., & Thompson, G. R. (1995) · Metabolism · doi:10.1016/0026-0495(95)90104-3 · Cited by 58
Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is
Havel, R. J., & Hamilton, R. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000115382.53810.24 · Cited by 59
Chetty, P. S., Mayne, L., Lund-Katz, S., Englander, S. W., & Phillips, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617523114 · Cited by 58
Paradis, A.-M., Fontaine‐Bisson, B., Bossé, Y., Robitaille, J., Lemieux, S., Jacques, H., Lamarche, B., Tchernof, A., Couture, P., & Vohl, M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.523 · Cited by 57
Korhonen, T., Savolainen, M. J., Koistinen, M. J., Ikäheimo, M. J., Linnaluoto, M. K., Kervinen, K., & Kesäniemi, Y. A. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05958-8 · Cited by 57
Braeckman, L., Bacquer, D. D., Rosseneu, M., & Backer, G. D. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05681-5 · Cited by 57
Winkelmann, B. R., & Hager, J. (2000) · Pharmacogenomics · doi:10.1517/14622416.1.1.73 · Cited by 57
The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects
Moreno, J. A., Pérez‐Jiménez, F., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Moreno‐Luna, R., Bellido, C., Fuentes, F. J., & López‐Miranda, J. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2517 · Cited by 57
Dyslipoproteinemia and Diabetes
Orchard, T. J. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30330-x · Cited by 57
Jarvik, G. P., Goode, E. L., Austin, M. A., Auwerx, J. H., Deeb, S. S., Schellenberg, G. D., & Reed, T. (1997) · The American Journal of Human Genetics · doi:10.1086/513902 · Cited by 57
Berr, C., Dufouil, C., Brousseau, T., Richard, F., Amouyel, P., Marceteau, E., & Alpérovitch, A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13059-7 · Cited by 57
Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease
Weiner, M., Vega, G., Risser, R. C., Honig, L. S., Cullum, C. M., Crumpacker, D., & Rosenberg, R. N. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00222-4 · Cited by 57
Hanis, C. L., Hewett‐Emmett, D., Douglas, T., Bertin, T., & Schull, W. J. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.362 · Cited by 57
Garai, K., Baban, B., & Frieden, C. (2011) · Biochemistry · doi:10.1021/bi1020106 · Cited by 57
Jazwinski, S. M. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00027-8 · Cited by 56
What do we mean by genetic testing?
Harper, P. S. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.9.749 · Cited by 56
Contributors to white matter damage in the frontal lobe in Alzheimer's disease
Chalmers, K. A., Wilcock, G., & Love, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00678.x · Cited by 57
Area-Gomez, E., Larrea, D., Pera, M., Agrawal, R. R., Guilfoyle, D. N., Pirhaji, L., Shannon, K., Arain, H. A., Ashok, A., Chen, Q., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61142-8 · Cited by 55
Metabolic disorder in Alzheimer’s disease
Poddar, M. K., Banerjee, S., Chakraborty, A., & Dutta, D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00673-z · Cited by 58
Karjalainen, J.-P., Mononen, N., Hutri-Kähönen, N., Lehtimäki, M., Juonala, M., Ala-Korpela, M., Kähönen, M., Raitakari, O., & Lehtimäki, T. (2019) · Scientific Reports · doi:10.1038/s41598-018-36450-9 · Cited by 55
Rontu, R., Ojala, P., Hervonen, A., Goebeler, S., Karhunen, P. J., Nikkilä, M. T., Kunnas, T. A., Jylhä, M. K., Eklund, C., Hurme, M., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02455.x · Cited by 55
Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo
Caldas, H., Holloway, M. P., Hall, B. M., Qualman, S. J., & Altura, R. A. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.034686 · Cited by 55
Statin use and the risk of Alzheimer's disease: The MIRAGE Study
Green, R. C., McNagny, S. E., Jayakumar, P., Cupples, L. A., Benke, K. S., Farrer, L. A., & MIRAGE Study Group (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.02.003 · Cited by 55
Davignon, J., & Roy, M. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90003-u · Cited by 55
Self-citationZarow, C., & Victoroff, J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6709 · Cited by 56
Effect of apoE genotype on the hypolipidaemic response to pravastatin in an outpatient setting
Peña, R., Lahoz, C., Mostaza, J. M., Jiménez, J., Subirats, E., Pintó, X., Taboada, M., López-Pastor, Á., & and The Rap Study Group (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00991.x · Cited by 55
Stengård, J., Pekkanen, J., Ehnholm, C., Nissinen, A. M., & Sing, C. F. (1996) · Human Genetics · doi:10.1007/bf02281882 · Cited by 56
Self-citationWoollett, L. A., Osono, Y., Herz, J., & Dietschy, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12500 · Cited by 55
Fagan, A. M., Christopher, E., Taylor, J. W., Parsadanian, M., Spinner, M., Watson, M., Fryer, J. D., Wahrle, S., Bales, K. R., Paul, S. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63399-8 · Cited by 54
Apolipoprotein E polymorphism, age and coronary heart disease
Kolovou, G. D., & Anagnostopoulou, K. K. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2006.11.001 · Cited by 54
Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables
Braeckman, L., Bacquer, D. D., Delanghe, J., Claeys, L. R., & Backer, G. D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00330-x · Cited by 54
Pouliot, M. C., Després, J., Dionne, F. T., Vohl, M., Moorjani, S., Prud’homme, D., Bouchard, C., & Lupien, P. J. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.527 · Cited by 54
Broderick, J. P., Lü, M., Jackson, C., Pancioli, A., Tilley, B. C., Fagan, S. C., Kothari, R., Levine, S. R., Marler, J. R., Lyden, P. D., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1058 · Cited by 54
Ilveskoski, E., Loimaala, A., Mercuri, M. F., Lehtimäki, T. J., Pasanen, M. E., Nenonen, A., Oja, P., Bond, M. G., Koivula, T. A., Karhunen, P. J., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00383-x · Cited by 54
Apolipoprotein E Polymorphism and Atherosclerosis
Kolovou, G. D., Daskalova, D. C., & Mikhailidis, D. P. (2003) · Angiology · doi:10.1177/000331970305400108 · Cited by 54
Lohse, P., Mann, W. A., Stein, E. A., & Brewer, H. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99249-5 · Cited by 54
Hara, M., Matsushima, T., Satoh, H., Iso-o, N., Noto, H., Togo, M., Kimura, S., Hashimoto, Y., & Tsukamoto, K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054199.78458.4b · Cited by 53
Prediction of genetic risk for dyslipidemia
Yamada, Y., Matsuo, H., Warita, S., Watanabe, S., Kato, K., Oguri, M., Yokoi, K., Metoki, N., Yoshida, H., Satoh, K., et al. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.001 · Cited by 54
Associations between apoE genotype and colon and rectal cancer
Slattery, M. L., Sweeney, C., Murtaugh, M. A., Ma, K.-N., Potter, J. D., Levin, T. R., Samowitz, W. S., & Wolff, R. K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi088 · Cited by 53
Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study
Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Tschanz, J. T., Norton, M. C., Khachaturian, A. S., Pieper, C. F., Welsh-Bohmer, K. A., Breitner, J. C. S., & for the Cache County Investigators (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53301.x · Cited by 53
Aslanidis, C., & Schmitz, G. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.1094 · Cited by 53
Lussier‐Cacan, S., Bolduc, A., Xhignesse, M., Niyonsenga, T., & Sing, C. F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000014589.22121.6c · Cited by 53
Self-citationImpact of Apo E Phenotype on the Regulation of Cholesterol Metabolism
Miettinen, T. A. (1991) · Annals of Medicine · doi:10.3109/07853899109148045 · Cited by 53
Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects.
Ferrières, J., Sing, C. F., Roy, M., Davignon, J., & Lussier‐Cacan, S. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1553 · Cited by 53
Self-citationLittle, D. P., Braun, A. D., Darnhofer-Demar, B., & Köster, H. (1997) · PubMed · Cited by 53
Sepehrnia, B., Kamboh, M. I., Adams-Campbell, L. L., Nwankwo, M. U., & Ferrell, R. E. (1988) · PubMed · Cited by 53
Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels
Brewer, H. B. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-620990-7.50018-8 · Cited by 53
Gotoh, N., Kuroiwa, S., Kikuchi, T., Arai, J., Arai, S., Yoshida, N., & Yoshimura, N. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.05.025 · Cited by 53
Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol
Weggemans, R. M., Zock, P. L., Ordovás, J. M., Pedro‐Botet, J., & Katan, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00720-6 · Cited by 52
Vaisi‐Raygani, A., Rahimi, Z., Nomani, H., Tavilani, H., & Pourmotabbed, T. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.06.010 · Cited by 52
Familial hypercholesterolemia in children
Rodenburg, J., Vissers, M. N., Wiegman, A., Trip, M. D., Bakker, H. D., & Kastelein, J. J. P. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137228.92396.f3 · Cited by 52
Pezzini, A., Grassi, M., Zotto, E. D., Bazzoli, E., Archetti, S., Assanelli, D., Akkawi, N. M., Albertini, A., & Padovani, A. (2004) · Stroke · doi:10.1161/01.str.0000112973.00867.98 · Cited by 52
Genetic Epidemiology of Coronary Artery Disease
Peyser, P. A. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017949 · Cited by 52
Kamboh, M. I., Weiss, K. M., & Ferrell, R. E. (1991) · Clinical Genetics · doi:10.1111/j.1399-0004.1991.tb02981.x · Cited by 52
Jarvik, G. P., Austin, M. A., Fabsitz, R. R., Auwerx, J. H., Reed, T., Christian, J. C., & Deeb, S. S. (1994) · Genetic Epidemiology · doi:10.1002/gepi.1370110407 · Cited by 52
Jousilahti, P., Vartiainen, E. A., Tuomilehto, J. O., Pekkanen, J., & Puska, P. (1998) · Annals of Medicine · doi:10.3109/07853899809002490 · Cited by 52
Pouliot, M. C., Després, J., Moorjani, S., Lupien, P., Tremblay, A., & Bouchard, C. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42742-7 · Cited by 52
The relationship between apolipoprotein E, dementia, and vascular illness
Marin, D. B., Breuer, B., Marin, M. L., Silverman, J. M., Schmeidler, J., Greenberg, D. A., Flynn, S. P., Mare, M., Lantz, M., Libow, L. S., et al. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00105-1 · Cited by 52
Zhang, X., Tian, Q., Liu, D., Geng, T., Xu, X., Ge, S., Zheng, D., Wu, L., Song, M., Hou, H., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0822-x · Cited by 51
The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease
Mishra, P., Davies, D. A., & Albensi, B. C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03152-3 · Cited by 51
Álvarez, A., del Castillo, I., Pera, A., Villamar, M., Moreno-Pelayo, M. Á., Rivera, T., Solanellas, J., & Moreno, F. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.636 · Cited by 51
Luo, J., Maréchal, J., Wärmländer, S. K. T. S., Gräslund, A., & Perálvarez‐Marín, A. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000663 · Cited by 51
Mortality and Apolipoprotein E in Hispanic, African-American, and Caucasian elders
Lee, J. H., Tang, M., Schupf, N., Stern, Y., Jacobs, D. M., Tycko, B., & Mayeux, R. P. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1528 · Cited by 51
Vohl, M., Lamarche, B., Moorjani, S., Prud’homme, D., Nadeau, A., Bouchard, C., Lupien, P.-J., & Després, J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.714 · Cited by 52
Srinivasan, S. R., Ehnholm, C., Wattigney, W. A., & Berenson, G. S. (1993) · Metabolism · doi:10.1016/0026-0495(93)90091-2 · Cited by 51
Räihä, I. J., Marniemi, J., Puukka, P. J., Toikka, T., Ehnholm, C., & Sourander, L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1224 · Cited by 51
Rubinsztein, D. C. (1995) · Psychological Medicine · doi:10.1017/s0033291700036138 · Cited by 51
Hu, M. L., Quinn, J., & Xue, K. (2021) · Life · doi:10.3390/life11070635 · Cited by 51
Genetic Susceptibility to Atherosclerosis
Kovacic, S., & Bakran, M. (2012) · Stroke Research and Treatment · doi:10.1155/2012/362941 · Cited by 50
Arbonés-Mainar, J. M., Johnson, L. A., Torres-Pérez, E., Whitlock, A. E. G., Pérez‐Díaz, S., Raber, J., & Maeda, N. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.93 · Cited by 52
Fallaize, R., Carvalho-Wells, A. L., Tierney, A. C., Marín, C., Kieć‐Wilk, B., Dembinska-Kiec, A., Drevon, C. A., Defoort, C., López‐Miranda, J., Risérus, U., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05802-2 · Cited by 54
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease
Seripa, D., Panza, F., Franceschi, M., D’Onofrio, G., Solfrizzi, V., Dallapiccola, B., & Pilotto, A. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.12.003 · Cited by 50
The Relationship between Apolipoprotein E4 and Lipid Metabolism Is Impaired in Alzheimer’s Disease
Dupuy, A., Mas, E., Ritchie, K. A., Descomps, B., Badiou, S., Cristol, J., & Touchon, J. (2001) · Gerontology · doi:10.1159/000052801 · Cited by 50
Campillos, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg435 · Cited by 50
Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma
Ribera, M., Pintó, X., Argimón, J. M., Fiol, C., Pujol, R., & Ferrándiz, C. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80224-1 · Cited by 50
Tziakas, D. N., Chalikias, G. K., Antonoglou, C., Veletza, S. V., Tentes, I. K., Kortsaris, A. X., Hatseras, D., & Kaski, J. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.032 · Cited by 51
Metadata
- Authors
- Davignon, J., Gregg, R. E., & Sing, C. F.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2066644955
- Cited by
- 1,981
- References
- 98
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 21 · 2020: 21 · 2019: 21 · 2018: 27 · 2017: 28 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 40 · 2012: 49
- FWCI
- 83.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis An Official Journal of the American Heart Association Inc (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL24489, HL-39107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE polymorphism, atherosclerosis, coronary artery disease, hyperlipidemia, LDL cholesterol, lipoprotein metabolism, gene-environment interaction, type III hyperlipoproteinemia, cardiovascular risk assessment, genetic susceptibility
- MeSH terms
- Alleles, Apolipoproteins, Apolipoproteins E, Arteriosclerosis, Coronary Disease, Humans, Lipids, Lipoproteins, Phenotype, Polymorphism, Genetic, Radiography, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
